Product Images Levetiracetam

This text provides instructions for calculating the total daily dose of a medication in mL/day based on the patient's weight and the daily dose in mg/kg/day. The medication is available in a concentration of 100 mg/mL.*

This text provides a formula to calculate CLer, which is a measure of renal function in patients. The equation requires the patient's age, weight, and serum creatinine level. For female patients, a certain value must be multiplied by the result of the equation. To further adjust for the patient's body surface area, a conversion factor is provided. CLer is expressed in mL/min and then adjusted to mL/min/1.73m^2.*

The text seems to be a table showing the percentage of patients for each group (Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day) in a clinical trial. The percentages range from 0% to 35.2%. However, there is not enough information to determine the specific purpose or results of the trial.*

This is a table showing the percentage of patients in a clinical trial who received either a placebo or levetiracetam. The percentages range from 0% to 44.6%. There are some unreadable characters in the text.*

This appears to be a graph or chart displaying percentages of patients for different categories. The categories are not provided but are likely related to treatment or outcomes. The percentages range from 0% to 100%. There are two groups listed, one treated with placebo (N=84) and the other with levetiracetam (N=79). There are specific percentages listed for each group, although it is unclear what information they represent.*